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Analysis of effectiveness
The analysis of effectiveness was conducted on an intention to treat basis. The outcomes assessed were: the lengths of pre-and postoperative hospital stay; the morbidity rate and postoperative complications; and the rate of target achievement at 24 hours and at days 4, 7 and 14.
The target after 24 hours was not having to monitor for vital signs using the intensive care nurse-chart every 1 to 2 hours. On the 4th day, the patients were checked to determine whether they could ambulate with the assistance of a nurse. On the 7th day, the patients were checked to see whether they could take liquid meals. On the 14th day, the patients were checked to see if they could be discharged from the hospital.
In terms of baseline characteristics, no significant differences were observed between the CP and control groups in terms of the patients' age, composition of genders, preoperative complications, anaesthesia risk, stages of gastric cancer and operative procedures.
Effectiveness results
The mean length of preoperative stay was 9.0 days (SD=3.2) for the CP group and 12.6 days (SD=6.0) for the control group, (p<0.001).
The mean length of postoperative stay was 18.1 days (SD=9.5) for the CP group and 28.2 days (SD=22.3) for the control group, (p<0.01).
The morbidity rate was 6% for the PC group and 13% for the control group. The difference was not significant.
Three postoperative complications were observed among the CP group (leakage, stenosis and gastro-stasis) versus 5 among the control group (abscess, blind loop syndrome, stenosis, pneumonia and cerebral infarction).
Among the patients who did not have postoperative complications, the length of pre-and postoperative hospital stay was also significantly shorter for the CP group, (p<0.001). The total hospital stay was 25.5 days (SD=4.8) in the CP group and 33.9 days (SD=10.2) in the control group.
However, among the patients who had postoperative complications, the length of hospital stay was not significantly different between the two groups, 50 days (SD=31.2) for the CP group versus 86.8 days (SD=49.3) for the control group.
In terms of target achievement, the CP group was found to be significantly better than the control group at all stages: at 24 hours, 87% for the CP group versus 54% for the control group, (p<0.005); on day 4, 98% (CP) and 78% (control), respectively, (p<0.05); on day 7, 91% (CP) and 68% (control), respectively, (p<0.05); and on day 14, 91% (CP) and 50% (control), respectively, (p<0.001).
This trend was also observed among the patients who had postoperative complications.
